PT  - JOURNAL ARTICLE
AU  - Gordon, Debra
ED  - Price, Matthew J.
TI  - High-Dose Clopidogrel in Patients with High Residual Reactivity: Results from the GRAVITAS Trial
DP  - 2010  01
TA  - MD Conference Express
PG  - 19--20
VI  - 10
IP  - 10
4099  - http://mdc.sagepub.com/content/10/10/19.short
4100  - http://mdc.sagepub.com/content/10/10/19.full
AB  - Doubling the dose of clopidogrel in patients with high residual platelet activity after percutaneous intervention has no significant effect on cardiovascular outcomes, according to the neutral results of the Gauging Responsiveness with A VerifyNow Assay—Impact on Thrombosis And Safety [GRAVITAS; NCT00645918] trial.